Advanced Refractory Left Ventricular Heart Failure — MOMENTUM 3 Continued Access Protocol
Citation(s)
Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3™ Continued Access Protocol: Post-Approval Continued Follow-up